Jon Frampton

1 - 20 out of 96Page size: 20

Publications

  1. 2019
  2. Published

    CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex

    Giacomo Volpe, Jon Frampton, 24 Jan 2019, In : Leukemia. 33, p. 1608-1619 12 p.

    Research output: Contribution to journal › Article

  3. 2018
  4. Published

    Fine-tuning Mybl2 is required for proper mesenchymal-to-epithelial transition during somatic reprogramming

    Carl Ward, Giacomo Volpe, Pierre Cauchy, Anetta Ptasinska, Jon Frampton & Paloma Garcia, 7 Aug 2018, In : Cell Reports. 24, 6, p. 1496-1511

    Research output: Contribution to journal › Article

  5. Published

    Inducible disruption of the c-myb gene allows allogeneic bone marrow transplantation without irradiation

    Jon Frampton, 1 Jun 2018, In : Journal of Immunological Methods. 457, p. 66-72

    Research output: Contribution to journal › Article

  6. Published

    Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research

    Sudha Sundar, Jean-Baptiste Cazier & Jon Frampton, 15 Feb 2018, In : The Lancet Oncology. 19, 2, p. e102–e112

    Research output: Contribution to journal › Article

  7. 2017
  8. Published

    Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature

    Giacomo Volpe, David Grainger, Carl Ward, Pierre Cauchy, Daniel Coleman, Peter Cockerill, Paloma Garcia & Jon Frampton, 11 Sep 2017, In : Scientific Reports. 7, 11148.

    Research output: Contribution to journal › Article

  9. Published

    Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1

    Philip Newsome, Jon Frampton & 4 others, , 17 Mar 2017, In : Journal of Biological Chemistry. 292, 11, p. 4755-4763 9 p.

    Research output: Contribution to journal › Article

  10. Published

    Targeting the transcription factor Myb by small-molecule inhibitors

    Jon Frampton, 1 Mar 2017, In : Experimental Hematology. 47, p. 31-35

    Research output: Contribution to journal › Article

  11. 2016
  12. E-pub ahead of print

    Transcriptional regulation of SPROUTY 2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3

    Mary Clarke, Giacomo Volpe, Lozan Sheriff, Carl Ward, Wenbin Wei, Stephanie Dumon, Paloma Garcia & Jon Frampton, 8 Nov 2016, In : Leukemia.

    Research output: Contribution to journal › Article

  13. 2015
  14. E-pub ahead of print

    Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction

    Emilie Dasse, Jon Frampton, 2 Dec 2015, In : Blood.

    Research output: Contribution to journal › Article

  15. Published

    Fibrin activates GPVI in human and mouse platelets

    Craig Hughes, Jon Frampton & Steve Watson, 24 Sep 2015, In : Blood. 126, 13, p. 1601-1608 8 p.

    Research output: Contribution to journal › Article

  16. Published

    Regulation of the Flt3 gene in haematopoietic stem and early progenitor cells

    Giacomo Volpe, Mary Clarke, Paloma Garcia, Alexandros Vegiopoulos, Walter Del Pozzo, Jon Frampton & Stephanie Dumon, 18 Sep 2015, In : PLoS ONE. 10, 9, e0138257.

    Research output: Contribution to journal › Article

  17. Published

    Pretreatment of Mesenchymal Stem Cells Manipulates Their Vasculoprotective Potential While Not Altering Their Homing Within the Injured Gut

    Dean Kavanagh, Philip Newsome, Jon Frampton & Neena Kalia, 24 Aug 2015, In : Stem Cells. 33, 9, p. 2785-97 13 p.

    Research output: Contribution to journal › Article

  18. Published

    Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development

    Kate Lowe, Brenda Finney, Jon Frampton, Christopher Buckley & Steve Watson, 11 Jun 2015, In : Blood. 125, 24, p. 3769-3777 9 p.

    Research output: Contribution to journal › Article

  19. Published

    Determining c-Myb protein levels can isolate functional hematopoietic stem cell subtypes

    Paloma Garcia, Jon Frampton, Feb 2015, In : Stem Cells. 33, 2, p. 479-490 12 p.

    Research output: Contribution to journal › Article

  20. Published

    The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters

    Jon Frampton & 1 others, , Jan 2015, In : Cell Research. 25, 1, p. 80-92 13 p.

    Research output: Contribution to journal › Article

  21. 2014
  22. Published

    Transcriptional pause release is a rate-limiting step for somatic cell reprogramming

    Yuan Li & 12 others, , Jon Frampton, 6 Nov 2014, In : Cell stem cell. 15, 5, p. 574-88 15 p.

    Research output: Contribution to journal › Article

  23. Published

    RAG1/2 knockout pigs with severe combined immunodeficiency

    Jon Frampton, 1 Aug 2014, In : Journal of Immunology. 193, 3, p. 1496-503 8 p.

    Research output: Contribution to journal › Article

  24. Published

    Generation of knockout rabbits using transcription activator-like effector nucleases

    Philip Newsome, Jon Frampton, 5 Feb 2014, In : Cell Regeneration . 3, 3.

    Research output: Contribution to journal › Article

  25. 2013
  26. Published

    Crosstalk between mesenchymal stem cells and endothelial cells leads to down-regulation of cytokine-induced leukocyte recruitment

    Nguyet -Thin Luu, Helen McGettrick, Christopher Buckley, Philip Newsome, Ed Rainger, Jon Frampton & Gerard Nash, Dec 2013, In : Stem Cells. 31, 12, p. 2690-2702

    Research output: Contribution to journal › Article

  27. Published

    Multi-modal molecular diffuse optical tomography system for small animal imaging

    Hector Basevi, Jon Frampton, Iain Styles & Hamid Dehghani, 10 Sep 2013, In : Measurement Science and Technology. 24, 10, 22 p., 105405.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 Next